Delivery Order SPE2DR25D7005-SPE2DR26F3FCZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,764.08 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This non-competitive, firm fixed-price delivery order was executed on January 27, 2026, with an ultimate completion date of January 28, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,899.35 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 25, 2025, one day after the award date. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.95 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This non-competitive, firm fixed-price delivery order was awarded on January 14, 2026, with an ultimate completion date of January 15, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,467.96 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. The contract is a firm fixed price delivery order with no set-aside designation, issued on December 4, 2025, with an ultimate completion date of December 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,217.64 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This firm fixed-price contract, awarded on January 20, 2026, with an ultimate completion date of January 21, 2026, represents a routine pharmaceutical supply delivery with no set-aside designation. The contractor, headquartered in Conshohocken, Pennsylvania, is the operating subsidiary of parent company Cencora, Inc., a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,535.65 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This is a firm fixed-price contract with no set-aside designation, competitively awarded on a full and open basis. The contract was awarded on January 23, 2026, with an ultimate completion date of January 26, 2026. Performance will take place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,341.66 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% foam in a 10-gram formulation. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,435.28 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. This non-set-aside, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $4,033.48 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This non-set-aside contract employs firm fixed-price pricing and is scheduled for completion by January 15, 2026, just one day after the award date of January 14, 2026. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,902.53 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram formulation, with an ultimate completion date of June 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a global...
- SPE2DR25D7005Indefinite Delivery Contract
- SPE2DR25D7005-SPE2DR26F3FCZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,130.87 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, non-set-aside contract with a completion date of January 30, 2026, issued on January 29, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026, which enables the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company was competitively awarded this delivery order through the DLA's open contracting process, demonstrating its capability to meet federal pharmaceutical supply requirements across multiple therapeutic domains. The parent company, Cencora, Inc., also maintains a larger indefinite delivery contract with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031, underscoring the company's significant role in the federal pharmaceutical supply chain supporting military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 1/28/26 |